Business Description
Innopharmax Inc
ISIN : TW0004172002
Total Employee Number:
26Description
Innopharmax Inc is a Taiwan based specialty pharmaceutical company. It is focused on the development and commercialization of products for the treatment of oncology and specialty. The company's products include anti-infection agents, contrast agents, oncology agents, immunological agents, drugs for rare diseases and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.99 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 13.94 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.3 | |||||
3-Year EBITDA Growth Rate | -14.4 | |||||
3-Year EPS without NRI Growth Rate | -12.9 | |||||
3-Year FCF Growth Rate | -2.9 | |||||
3-Year Book Growth Rate | -7.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.86 | |||||
9-Day RSI | 71.02 | |||||
14-Day RSI | 63.27 | |||||
3-1 Month Momentum % | -24.26 | |||||
6-1 Month Momentum % | -26.87 | |||||
12-1 Month Momentum % | -33.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.52 | |||||
Quick Ratio | 3.22 | |||||
Cash Ratio | 3.11 | |||||
Days Inventory | 109.88 | |||||
Days Sales Outstanding | 21.05 | |||||
Days Payable | 36.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 14.25 | |||||
Operating Margin % | -248.98 | |||||
Net Margin % | -267.29 | |||||
EBITDA Margin % | -252.49 | |||||
FCF Margin % | -194.52 | |||||
OCF Margin % | -194.52 | |||||
ROE % | -35.12 | |||||
ROA % | -32.58 | |||||
ROIC % | -53.27 | |||||
3-Year ROIIC % | 107.78 | |||||
ROC (Joel Greenblatt) % | -1337.2 | |||||
ROCE % | -34.36 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 20.88 | |||||
PB Ratio | 3.45 | |||||
Price-to-Tangible-Book | 3.48 | |||||
EV-to-EBIT | -8.02 | |||||
EV-to-EBITDA | -8.31 | |||||
EV-to-Revenue | 20.96 | |||||
EV-to-FCF | -9.44 | |||||
Price-to-GF-Value | 0.44 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Net-Current-Asset-Value | 11.47 | |||||
| Price-to-Net-Cash | 13.71 | |||||
Earnings Yield (Greenblatt) % | -12.48 | |||||
FCF Yield % | -8.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Innopharmax Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 68.987 | ||
| EPS (TTM) (NT$) | -1.699 | ||
| Beta | 0.2617 | ||
| 3-Year Sharpe Ratio | -0.83 | ||
| 3-Year Sortino Ratio | -1.05 | ||
| Volatility % | 35.48 | ||
| 14-Day RSI | 63.27 | ||
| 14-Day ATR (NT$) | 0.805136 | ||
| 20-Day SMA (NT$) | 11.6075 | ||
| 12-1 Month Momentum % | -33.93 | ||
| 52-Week Range (NT$) | 10.1 - 23.591778 | ||
| Shares Outstanding (Mil) | 119.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Innopharmax Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Innopharmax Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Innopharmax Inc Frequently Asked Questions
What is Innopharmax Inc(ROCO:4172)'s stock price today?
The current price of ROCO:4172 is NT$13.30. The 52 week high of ROCO:4172 is NT$23.59 and 52 week low is NT$10.10.
When is next earnings date of Innopharmax Inc(ROCO:4172)?
The next earnings date of Innopharmax Inc(ROCO:4172) is .
Does Innopharmax Inc(ROCO:4172) pay dividends? If so, how much?
Innopharmax Inc(ROCO:4172) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Innopharmax Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers